Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes

被引：0
|
作者：
Morozova, Christine [1 ]
Humayun, Lucas [1 ,2 ]
Tabandeh, Homayoun [1 ]
Boyer, David S. [1 ]
Dayani, Pouya N. [1 ,3 ]
Rahhal, Firas M. [1 ,3 ]
机构：
[1] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[2] Duke Univ, Durham, NC USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2652
引用
收藏
页数：3
相关论文
共 50 条
  • [21] RETINAL THICKNESS RESULTS PRIOR AND FOLLOWING TREATMENT WITH 0.19 MG FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA
    Carneiro, Angela M.
    Meireles, Angelina
    Sousa, Joao
    Teixeira, Carla
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
    Kessler, Lucy Joanne
    Labuz, Grzegorz
    Auffarth, Gerd U.
    Khoramnia, Ramin
    PHARMACEUTICS, 2022, 14 (04)
  • [23] Optical Coherence Tomography Biomarkers: Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19-mg Fluocinolone Acetonide Implant
    Pessoa, Bernardete
    Ferreira, Andre
    Leite, Joao
    Figueira, Joao
    Meireles, Angelina
    Beirao, Joao Melo
    OPHTHALMIC RESEARCH, 2021, 64 (04) : 639 - 647
  • [24] IS THE DIABETIC MACULAR EDEMA CHRONICITY A PROGNOSTIC FACTOR FOR FUNCTIONAL AND ANATOMIC OUTCOMES IN PATIENTS TREATED WITH 0.19 MG FLUOCINOLONE ACETONIDE IMPLANT?
    Meireles, Angelina
    Coelho, Joao
    Silva, Nisa
    Marta, Ana
    Beirao, Joao
    Pessoa, Bernardete
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edema
    Augustin, Albert J.
    Bopp, Silvia
    Fechner, Martin
    Holz, Frank G.
    Sandner, Dirk
    Winkgen, Andrea-M
    Khoramnia, Ramin
    Neuhann, Thomas
    Warscher, Markus
    Spitzer, Martin S.
    Sekundo, Walter
    Seitz, Berthold
    Duncker, Tobias
    Ksinsik, Christian
    Hoeh, Helmut
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (02) : 1101 - 1108
  • [26] Diabetic macular edema: Fluocinolone acetonide intravitreal reduces treatment burden
    Merrill, P. T.
    AUGENHEILKUNDE UP2DATE, 2024, 14 (01) : 7 - 8
  • [27] Diabetic Macular Edema: Intravitreal Fluocinolone Acetonide reduces the Treatment Burden
    Thieme, Eve-Claudia
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2023, 240 (09) : 1040 - +
  • [28] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
    Lima-Fontes, Mario
    Leuzinger-Dias, Mariana
    Barros-Pereira, Ricardo
    Fernandes, Vitor
    Falcao, Manuel
    Falcao-Reis, Fernando
    Rocha-Sousa, Amandio
    Alves-Faria, Pedro
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 377 - 388
  • [29] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
    Mário Lima-Fontes
    Mariana Leuzinger-Dias
    Ricardo Barros-Pereira
    Vítor Fernandes
    Manuel Falcão
    Fernando Falcão-Reis
    Amândio Rocha-Sousa
    Pedro Alves-Faria
    Ophthalmology and Therapy, 2023, 12 : 377 - 388
  • [30] Effective Duration of Fluocinolone Acetonide (FAc) Implant in the Treatment of Diabetic Macular Edema
    Saigal, Khushi
    El Hamichi-Potamkin, Sophia
    Khurshid, Syed Gibran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345